E. Tribollet et al., Binding of the non-peptide vasopressin V-1a receptor antagonist SR-49059 in the rat brain: An in vitro and in vivo autoradiographic study, NEUROENDOCR, 69(2), 1999, pp. 113-120
A potent non-peptide vasopressin (AVP) antagonist, SR-49059, displaying hig
h stability and selective affinity for the V-1a AVP receptor subtype, has r
ecently been described. The objective of this study was to assess the bindi
ng properties and the penetrability of this compound in the rat brain. Both
in vitro and in vivo binding autoradiography experiments were performed. I
n all studies, the liver was used as a reference V-1a tissue. In vitro labe
lling of rat brain sections with [H-3]SR-49059 was similar to that previous
ly detected with [H-3]AVP, which confirms that the majority of central AVP
binding sites are V-1a sites similar to peripheral V-1a receptors. As expec
ted, intense specific labelling occurred mainly in the lateral septum, the
fundus striatum, the hypothalamic stigmoid nucleus and the area postrema-nu
cleus of the solitary tract complex. In vivo binding autoradiography showed
that [H-3]SR-49059 injected intravenously did not enter the brain parenchy
ma. Specific labelling was however clearly detectable in brain regions with
permeable hematoencephalic barrier, the choroid plexus and other circumven
tricular organs expressing V-1a receptors, namely the subfornical organ, th
e pineal gland and the area postrema. The specificity of [H-3]SR-49059 bind
ing in the latter structures was confirmed by the fact that labelling was p
revented by pretreatment of animals with high doses of nonradioactive SR-49
059. In conclusion, our study shows that [H-3]SR-49059 is a suitable probe
to investigate V-1a receptors in the rat brain. We also demonstrate that al
though this compound is not able to enter the brain tissue from the periphe
ral circulation, it does bind specifically to regions devoid of blood-brain
barrier and known to be involved in autonomic regulations.